Delivery of DNA mixed with a degradable matrix carrier was supposed to improve transgene expression. Using a rabbit hind-limb ischemia model, we tested the angiogenic potency of plasmid encoding human vascular endothelial growth factor (pSG5-VEGF165) entrapped in fibrin sealant. Animals were injected intramuscularly with 500 μg of pSG5-VEGF165 or control plasmid, dissolved in saline (PBS) or fibrin glue. After 14 days, presence of delivered constructs and expression of transgene was confirmed in injected muscles of all animals. There were no significant differences in the levels of human VEGF mRNA and protein between VEGF-PBS and VEGF-fibrin groups (Mann-Whitney test). Accordingly, pSG5-VEGF165 regardless of the way of delivery, induced similar increases in capillary density within treated muscles (ANOVA). Control plasmid did not show any effects. In conclusion, injection of pSG5-VEGF165 into ischemic adductor muscle leads to synthesis of human VEGF and increases the number of capillaries. Fibrin carrier does not influence its angiogenic potential.
SchaperW., BuschmannI.VEGF and therapeutic opportunities in cardiovascular diseases. Curr Opin Biotechnol1999; 10: 541–3.
2.
TakeshitaS., IsshikiT., OchiaiM.Endothelium-dependent relaxation of collatral microvessels after intramuscullar gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation1998; 98: 2161–3.
3.
TakeshitaS., TsurumiY., CouffinahlT.Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest1996; 75: 487–501.
4.
TsurumiY., KearneyM., ChenD.Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation1997; 96(suppl 9): S382–8.
5.
TsurumiY., TakeshitaS., ChenD.Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation1996; 94: 3281–90.
6.
DulakJ., PartykaL., JozkowiczA.Gene transfer of naked VEGF plasmid induces the formation of microvessels but not mature collaterals in ischemic limb muscles. Eur Surg2002; 34: 105–10.
7.
TakeshitaS., IsshikiT., MonH.Microangiographic assessment of collateral vessel formation following direct gene transfer of vascular endothelial growth factor in rats. Cardiovasc Res1997; 35: 547–52.
8.
GowdakL.H., PoliakowaL., GroveR., LakaffaE.G., TalanM.Induction of angiogenesis by cationic lipid-mediated VEGF-165 gene transfer in the rabbit ischemic hindlimb. J Vasc Surg2000; 32: 343–52.
9.
NeumeisterM.W., SongY.H., MowlaviA., SuchyH., MathurA.Effects of liposome-mediated gene transfer of VEGF in isehemic rat gracilis muscle. Microsurgery2001; 21: 58–62.
10.
WeiszA., KorenB., FischerL., LewisB.S., FlugelmanM.Y.Therapeutic angiogenesis for ischemic syndromes. Isr Med Assoc 32000; 2: 52–7.
11.
RivardA., SilverM., ChenD.Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol1999; 154: 355–63.
BonadioJ., GoldsteinS.A., LevyR.J.Gene therapy for tissue repair and regeneration. Adv Drug Deliv Rev1998; 33: 53–69.
15.
OchiyaT., TakahamaY., NagaharaS.New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the minipellet. Nat Med1999; 5: 707–9.
16.
BonadioJ., SmileyE., PatilP., GoldsteinS.Localizes, direct plasmid-gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med1999; 5: 753–9.
17.
BonadioJ.Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Adv Drug Deliv Rev2000; 44: 185–94.
18.
HanS., MahatoR.I., SungY.K., KimS.W.Development of biomaterials for gene therapy. Mol Ther2000; 2: 302–17.
19.
FangJ., ZhuY.Y., SmileyE.Stimulation of new bone formation by direct transfer of osteoinductive plasmid genes. Proc NatI Acad Sci1996; 93: 5753–8.
20.
KlughertzB.D., JonesP.L., CuiX., ChenW., MeneveauN.F., De FeliceS.Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol2000; 18: 1181–4.
21.
KohJ.J., KoK.S., LeeM., HanS., ParkJ.S., KimS.W.Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene Ther2000; 7: 2099–104.
22.
MaheshwariA., MahatoR.I., McGregorJ.Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Mol Ther2000; 2: 121–30.
23.
RedIH., SchlagG., StanekG., HirschlA., SeelichT.In vitro properties of mixtures of fibrin seal and antibiotics. Biomaterials1983; 4: 29–32.
24.
ZischA.H., SchenkU., SchenseJ.C., Sakiyama-ElbertS.E., HubbellJ.A.Covalently conjugates VEGF-fibrin matrices for endothelialization. J Control Rel2001; 72: 101–13.
25.
KipshidzeN., ChekanovV., ChawlaP., ShankarL.R., GossetJ.B., KumarK.Angiogenesis in patient with ischemic limb. Induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. Tex Heart Inst J2000; 27: 196–200.
26.
ClarkR.A.F., LaniganJ.M., DellaPelleP., MansequE., DvorakH.F., ColvinR.B.Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol1982; 79: 264–9.
27.
ChekanovV., NikolaychikV., TchekanovG.The use of biologic glue for beffer adhesion between the skeletal muscle flap and the myocardium and for increasing capillary ingrowth. J Thorac Cardiovasc Surg1996; 111: 678–80.
28.
ChekanovV.S., TchekanovG.V., RiederM.A.Biologic glue increases capillary growth after cardiomyoplasty in an ischemic cardiomyopathy model. ASAIO J1996; 42: M630–6.
29.
DulakJ., JózkowiczA., GuevaraI., Dembińska-Kieć. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase - implications for gene therapy in cardiovascular disease. Pol J Pharmacol1999; 51: 233–41.
30.
DulakJ., JózkowiczA., RatajskaA., SzubaA., CookeJ.P., Dembińska-Kiec'A.Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSGSVEGF plasmids in vascular smooth muscle cells. Vasc Med2000; 5: 33–40.
31.
ManiatisT., FritshE.F., SambrookJ.1982. Molecular cloning: a laboratory manual.2nd edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratories.
32.
TakeshitaS., WeirL., ChenD.Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in rabbit model of hindlimb ischemia. Biochem Biophys Res Commun1996; 227: 628–35.
33.
WatkinsR., D'AngioC.T., RyanR.M., PatelA., ManiscalcoW.M.Differential expression of VEGF mRNA splice variants in newborn and adult hypoxic lung injury. Am J Physiol1999; 276: L858–67.
34.
ZiadaA.M., HudlickaG., TylerK.R., WrightA.J.The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res1984; 18: 724–32.
35.
MajeskyM.A little VEGF goes a long way. Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA. Circulation1996; 94: 3062–4.
36.
CherngJ.M., LinC.M., LinC.L., HuangS.M., ChangH.L., LeeC.C.Effects of VEGFI21 and/or VEGF 165 gene transfection on collateral circulation developments. J Formos Med Assoc2000; 99: 603–11.
37.
IsmailF.A., NapapornJ., HughesJ.A., BrazeauG.A.In situ gel formulation for gene delivery: release and myotoxicity studies. Pharm Dev Technol2000; 5: 391–7.
38.
BonadioJ.Tissue engineering via local gene delivery. J Mol Med2000; 78: 303–11.
39.
BerryM., GonzalezA.M., ClarkeW.Sustained effects of gene activated matrices after CNS injury. Mol Cell Neurosci2001; 17: 706–16.
40.
LabhasetwarV., BonadioJ., GoldsteinS., ChenW., LevyR.I.A DNA controlled-release coating for gene transfer: transfection in skeletal muscle and cardiac muscle. J Pharm Sci1998; 87: 1347–50.
41.
SheaL.D., SmilneyE., BonadioJ., MooneyD.J.Controllable DNA delivery from three-dimentional polymer matrices. Nat Biotechnol1999; 17: 551–4.
GhulamM.A.K., YoshimineT., MarunoM., TakemotoO., HayakawaT.Topical application of fibrin adhesive in the rat brain: effects on different cellular elements of the wound. Neurol Res1997; 19: 84–8.
44.
FasolR., SchumacherB., SchlaudraffK., HausensteinK.H., SeitelbergerR.Experimental use of the modified fibrin glue to induce site-directed angiogenesis from the aorta to the heart. J Thorac Cardiovasc Surg1994; 107: 1432–9.
